Skip to content

Proteasome Inhibitors in Cancer Therapy

Sold out
Original price Rs. 2,500.00
Original price Rs. 2,500.00 - Original price Rs. 2,500.00
Original price Rs. 2,500.00
Current price Rs. 2,000.00
Rs. 2,000.00 - Rs. 2,000.00
Current price Rs. 2,000.00
Condition: New

Exclusive Deals | Easy Replacement | Safe Checkout

💰 Get Cashback up to ₹250 on first Simpl payment

🎁 Use coupon code WELCOME to get discount on first order

🎁 Earn Reward Points on every purchase

📚 View Condition Chart of Books

New: These are new books which have been purchased from publishers and authors.

Almost New: These are books which have been read previously or are excess stock from bookshops and publishers. 

Good: These are the books which have have been sourced from book lovers and are in very good condition. They may have signs of ageing but will be in pretty good condition. 

Readable: These books may be old and have visible wear and tear signs. 

Learn more about our condition criteria here.

🚚 Read Our Free Shipping Policy

All prepaid orders above ₹299 are eligible for free shipping. Have more queries? Read more about our shipping and delivery policies here.

🔙 Super Easy Replacement Policy
A panel of leading academic and pharmaceutical investigators takes stock of the remarkable work that has been accomplished to date with proteasome inhibitors in cancer, and examines emerging therapeutic possibilities. The topics range from a discussion of the chemistry and cell biology of the proteasome and the rationale for proteasome inhibitors in cancer to a review of current clinical trials underway. The discussion of rationales for testing proteasome inhibitors in cancer models covers the role of the proteasome in NF-kB activation, the combining of conventional chemotherapy and radiation with proteasome inhibition, notably PS-341, new proteasome methods of inhibiting viral maturation, and the role of protesome inhibition in the treatment of AIDS. The authors also document the development of bortezomib (Velcade(TM)) in Phase I clinical trials and in a multicentered Phase II clinical trials in patients with relapsed and refractory myeloma.

Bookish Santa's Promise

Genuine Books

No pirated copies ever

5 Quality Checks

No Quality Compromise

Careful Packaging

Books arrive to you safely

100% Satisfaction

Because we care for you

More Information:

Publisher: Humana Press
Language: English
Binding: Hardcover
Pages: 313
ISBN: 9781588292506

Related Categories: All Books Collectibles English Books Hardcover Editions Newest Products

Popular Categories

Customer Reviews

No reviews yet
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)